News summary

Indivi strengthens AI capabilities for brain analysis with Cogitat acquisition

Source: Startupticker.ch • Published: 17 Nov 2026, 00:00

Summarized by Masters of Longevity from Startupticker.ch.

Indivi bought UK spinout Cogitat to add NeuroRVQ EEG AI to its platform.

Indivi strengthens AI capabilities for brain analysis with Cogitat acquisition
Key Takeaways
  • Indivi is expanding AI EEG analysis after acquiring Cogitat.
  • NeuroRVQ was reported to preserve fine, fast-changing brain signal detail.
  • Clinical impact remains unproven; observational work is not causal.
Read the full article at Startupticker.ch ↗

Continue exploring

Recommended MoL Picks

MoL PickWhat Changes in the Human Hippocampus with Age?A study of 40 postmortem brains maps a midlife shift in immune cells and a wider loss of cellular and genome organisation—but it does not show how to prevent cognitive decline.MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.MoL PickMelatonin and Heart Failure: What the Evidence Actually ShowsA 2025 study linked melatonin use with heart failure. A 2026 analysis found no significant association. Their different designs explain why the question remains open.